Clinical trial
Autologous Followed by Non-myeloablative Allogeneic Transplantation for…
NCT00481832 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00481832 |
|---|---|
| Title | Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma |
| Official title | Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma |
| Lead sponsor | Stanford University, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin |
| Intervention type | Drug, Procedure |
| Interventions | Cyclophosphamide, BCNU, Etoposide, Filgrastim, Antithymocyte globulin, Cyclosporine, Mycophenolate mofetil, Rituximab, Autologous hematopoietic stem cell transplantation (auto-HSCT), Allogeneic hematopoietic stem cell transplantation (allo-HSCT) and 3 more |
| Enrollment | 50 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 27, 2014 |
| Completion | Mar 30, 2017 |
| First posted | Jun 4, 2007 |
| Last update posted | Feb 14, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: